Skip to main content

Advertisement

Table 1 Number of patients, age at inclusion, allele frequencies and genotypes in patients and controls

From: APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway

  Number (Females/Males) Age at inclusion ± SD Allele frequencies (%) Genotypes
    ε2 ε3 ε4 ε2/ε2 ε2/ε3 ε2/ε4 ε3/ε3 ε3/ε4 ε4/ε4
Alzheimer patients All 376 79.5 ± 8.2 7.3 53.1 39.6 0.3 7.4 6.6 28.2 42.3 15.2
  F 263 80.3 ± 8.3 7.6 52.9 39.5 0.4 6.8 7.6 28.5 41.8 14.8
  M 113 77.5 ± 7.6 6.6 53.5 39.8 0.0 8.8 4.4 27.4 43.4 15.9
Control persons All 561 75.1 ± 7.3 11.3 74.3 14.3 0.7 17.1 4.1 55.8 20.0 2.3
  F 338 74.7 ± 7.1 10.9 74.4 14.3 0.6 16.6 4.1 55.9 21.0 1.8
  M 223 75.7 ± 7.5 11.9 73.8 14.3 0.9 17.9 4.0 55.6 18.4 3.1
  1. F = females
  2. M = males
  3. SD = Standard Deviation